Patents by Inventor Chin-Wen Chi

Chin-Wen Chi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Docetaxel for Treating Hepatocellular Carcinoma
    Publication number: 20080045584
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 ?M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: June 12, 2007
    Publication date: February 21, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Chin-Wen CHI, Heng-Liang LIN, Tsung-Yun LIU, Wing-Yiu LUI, Gar-Yang CHAU
  • Use of docetaxel for treating hepatoma
    Publication number: 20030158249
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 &mgr;M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: February 27, 2002
    Publication date: August 21, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Chin-Wen Chi, Heng-Liang Lin, Tsung-Yun Liu, Wing-Yiu Lui, Gar-Yang Chau
  • Cell cycle regulator protein
    Publication number: 20030027171
    Abstract: This invention relates to new cell cycle regulatory proteins and nucleic acids encoding them.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 6, 2003
    Inventors: Chu-Wen Yang, Ann-Ping Tsou, Chin-Wen Chi, Ming-Ji Fann, Chen-Kung Chou